SCYX FY 2019 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena

SCYXSCYNEXIS, Inc.

$37M

FY 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$121,000-52.9% YoY

Gross Profit

$121,000100.0% margin

Operating Income

-$49M-40430.6% margin

Net Income

-$54M-44388.4% margin

EPS (Diluted)

$-9.85

Cash Flow

Operating Cash Flow

-$38M

Free Cash Flow

-$38M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$57M

Total Liabilities

$44M

Stockholders' Equity

$13M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$121,000	$257,000	-52.9%
Gross Profit	$121,000	$257,000	-52.9%
Operating Income	-$49M	-$30M	-63.2%
Net Income	-$54M	-$12M	-330.8%